| 刘会雪,牛立远,张佩佩,等.急性胰腺炎病人血清长链非编码 RNA核富集转录体 1、 Toll样受体 2表达变化及临床意义研究[J].安徽医药,2023,27(9):1814-1818. |
| 急性胰腺炎病人血清长链非编码 RNA核富集转录体 1、 Toll样受体 2表达变化及临床意义研究 |
| Changes and clinical significance of serum LncRNA NEAT1 and TLR2 expressions in patients with acute pancreatitis |
| |
| DOI：10.3969/j.issn.1009-6469.2023.09.026 |
| 中文关键词: 急性胰腺炎 长链非编码 RNA核富集转录体 1 Toll样受体 2 逆转录聚合酶链反应 表达 临床意义 |
| 英文关键词: Acute pancreatitis Long non-coding RNA nuclear-enriched abundant transcript 1 Toll-like receptor 2 Reverse transcriptase polymerase chain reaction Expression Clinical significance |
| 基金项目: |
|
| 摘要点击次数: 402 |
| 全文下载次数: 259 |
| 中文摘要: |
| 目的探讨急性胰腺炎( AP)病人血清长链非编码 RNA核富集转录体 1(LncRNA NETA1)、 Toll样受体 2(TLR2)表达及临床意义。方法选取 2017年 5月至 2020年 12月石家庄平安医院收治的 AP病人 125例为研究对象，根据急性生理学和慢性健康状况评价 Ⅱ(APACHEⅡ)对 AP病人进行评分，并将病人分为轻症组 56例，重症组 69例；根据住院期间重症组 AP病人预后情况，将病人分为预后不良 25例，预后良好 44例。同期选取该院健康体检者 130例为健康组。实时荧光定量逆转录聚合酶链反应( qRT-PCR)检测血清 LncRNA NETA1水平，酶联免疫吸附测定( ELISA)检测血清 TLR2水平； Pearson相关性分析探索 AP病人血清 LncRNA NEAT1、TLR2水平相关性及二者与病人 APACHEⅡ评分的关系；受试者操作特征曲线( ROC曲线)分析血清 LncRNA NEAT1、TLR2对 AP病人重症的评估价值。结果与健康组比较， AP组血清 LncRNA NEAT1(2.16±0.31比1.00±0.00)、 TLR2水平［(6.43±1.05)μg/L比( 0.59±0.24)μg/L］升高( P<0.05)；与轻症组比较，重症组 AP病人血清 LncRNA NEAT1(2.31±0.33比 1.98±0.27)、 TLR2水平［( 6.89±1.16)μg/L比( 5.86±0.92)μg/L］升高(P<0.05)；与预后良好组比较，预后不良组重症 AP病人血清 LncRNA NEAT1(2.43±0.36比 2.14±0.27)、 TLR2水平［( 7.12±1.24)μg/L比( 6.45±1.02)μg/L］升高(P<0.05)； Pearson相关性分析结果表明， AP病人血清 LncRNA NEAT1、TLR2呈正相关( r=0.65，P<0.05)，二者与病人 APACHEⅡ评分均呈正相关( r=0.50、0.52，P<0.05)； ROC曲线结果显示，血清 LncRNA NEAT1水平、 TLR2单独及联合评估 AP病人重症的曲线下面积( AUC)分别为 0.73［95%CI:(0.64，0.82)］、 0.75［95%CI:(0.67，0.84)］、 0.88［95%CI:(0.82，0.94)］，血清 LncRNA NEAT1联合 TLR2水平预测 AP病人重症的 AUC明显大于二者单独预测( P<0.05)。结论 AP病人血清 LncRNA NEAT1、 TLR2表达水平显著升高，且与病人严重程度和预后有关，临床上检测 LncRNA NEAT1、TLR2表达可能有助于 AP病人的病情评估。 |
| 英文摘要: |
| Objective To investigate the expressions and clinical significance of long non-coding RNA nuclear-enriched transcript 1 (LncRNA NETA1) and Toll-like receptor 2 (TLR2) in the serum of patients with acute pancreatitis (AP).Methods A total of 125 AP patients admitted to Shijiazhuang Pingan Hospital from May 2017 to December 2020 were selected as the research objects. AP patientswere scored according to the Acute Physiology and Chronic Health Evaluation Scoring System Ⅱ (APACHEⅡ), and the patients wereclassified as 56 cases in the mild group, 69 cases in the severe group; according to the prognosis of severely ill AP patients during hos-pitalization, the patients were assigned into 25 cases with poor prognosis and 44 cases with good prognosis. Meanwhile, 130 healthy in-dividuals undergoingphysical examination in the same hospital were selected as the healthy group. Real-time fluorescent quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect serum LncRNA NETA1 level, enzyme-linked immuno- sorbent assay (ELISA) to detect serum TLR2 level. Pearson correlation method was used to analyze the correlation between serum Ln-cRNA NEAT1 and TLR2 levels in AP patients and their relationship with the APACHEⅡ score; receiver operator characteristic curves(ROC) curve was used to analyze the evaluation value of serum LncRNA NEAT1 and TLR2 in severely ill patients with AP.Results Compared with the healthy group, the serum LncRNA NEAT1 [(2.16±0.31) vs. (1.00±0.00)] and TLR2 levels [(6.43±1.05) μg/L vs. (0.59±0.24) μg/L] in the AP group were increased (P<0.05); compared with the mild group, the serum LncRNA NEAT1 [(2.31±0.33) vs. (1.98±0.27)] and TLR2 levels [(6.89±1.16) μg/L vs. (5.86±0.92) μg/L] of AP patients in the severe group were increased (P<0.05). Com- pared with the good prognosis group, the serum LncRNA NEAT1 [(2.43±0.36) vs. (2.14±0.27)] and TLR2 levels [(7.12±1.24) μg/L vs. (6.45±1.02) μg/L] of severe AP patients in the poor prognosis group were increased (P<0.05). The results of Pearson correlation analy-sis showed that serum LncRNA NEAT1 and TLR2 of AP patients were positively correlated (r=0.65, P<0.05), and both were positively correlated with the patient's APACHEⅡ score (r=0.50, 0.52, P<0.05). The ROC curve results showed that the areas under the curve(AUC) of serum LncRNA NEAT1 level and TLR2 alone and in combination for assessing severe AP were 0.73 [95% CI: (0.64, 0.82)],0.75 [95% CI: (0.67, 0.84)] and 0.88 [95% CI: (0.82, 0.94)], respectively; the AUC of severe AP patients predicted by the level of serumLncRNA NEAT1 combined with TLR2 was significantly higher than that predicted by both alone (P<0.05).Conclusions Serum Ln- cRNA NEAT1 and TLR2 expression levels in AP patients are significantly increased, and are related to the severity and prognosis ofpatients. Clinical detection of LncRNA NEAT1 and TLR2 expressions may be helpful for the assessment of the condition of AP patients. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
